一种多功能神经肽Y偶联物的设计、合成及生物学评价:用于放射性镧系元素的选择性核内递送
本研究设计了一种靶向人Y1受体的多功能神经肽Y偶联物pb12,通过脂肪酸、组织蛋白酶B可切割连接子、核定位序列和DOTA螯合剂修饰[F7,P34]-NPY,并用铽-159或铟-111标记。该偶联物在MCF-7细胞中保持高亲和力并诱导受体内化,且证实铟-111随时间依赖性进入细胞核,但在人血浆中稳定性不足,小鼠体内仅在极早期时间点显示特异性摄取。
要点
- pb12偶联物保持对hY1R的高结合亲和力并诱导受体内化。
- 证实铟-111标记偶联物可时间依赖性进入MCF-7细胞核。
- 该肽在人血浆中稳定性不足,体内仅在极早期时间点有特异性摄取。
核心结论
- 带有可释放DOTA-NLS单元的多功能NPY偶联物是增强奥歇电子发射放射性镧系元素靶向放射治疗的有前景概念。
- 目前研究正致力于改善该放射性肽的血浆稳定性。
研究设计与样本
- 本研究为概念验证性研究,通过固相肽合成法将hY1R偏好性的[F7,P34]-NPY修饰脂肪酸、组织蛋白酶B可切割连接子、核定位序列和DOTA螯合剂,得到化合物pb12。
- 标记分别使用天然铽-159作为铽-161的替代物或铟-111进行。
- 体外实验使用MCF-7细胞,体内实验使用荷MCF-7异种移植瘤的裸鼠。
主要发现
- [natTb]Tb-pb12对MCF-7细胞上内源性hY1R保持高结合亲和力,并能诱导与[F7,P34]-NPY相似的受体激活和内化。
- 观察到铟-111标记偶联物特异性内化进入MCF-7细胞,并证实铟-111随时间依赖性进入细胞核。
- 代谢稳定性研究显示该肽在人血浆中稳定性不足。
- 在荷MCF-7异种移植瘤的裸鼠中注射[111In]In-pb12后,仅在极早期时间点显示特异性摄取。
关键数值与推荐
- 未报告
临床怎么用
- 原文未据此给出推荐。
局限性
- 该肽在人血浆中稳定性不足。
- 在荷MCF-7异种移植瘤的裸鼠中,[111In]In-pb12仅在极早期时间点显示特异性摄取。
- 目前研究正致力于改善该放射性肽的血浆稳定性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Targeting G protein-coupled receptors on the surface of cancer cells with peptide ligands is a promising concept for the selective tumor delivery of therapeutically active cargos, including radiometals for targeted radionuclide therapy (TRT). Recently, the radiolanthanide terbium-161 (161Tb) gained significant interest for TRT application, since it decays with medium-energy β-radiation but also emits a significant amount of conversion and Auger electrons with short tissue penetration range. The therapeutic efficiency of radiometals emitting Auger electrons, like 161Tb, can therefore be highly boosted by an additional subcellular delivery into the nucleus, in order to facilitate maximum dose deposition to the DNA. In this study, we describe the design of a multifunctional, radiolabeled neuropeptide-Y (NPY) conjugate, to address radiolanthanides to the nucleus of cells naturally overexpressing the human Y1 receptor (hY1R). By using solid-phase peptide synthesis, the hY1R-preferring [F7,P34]-NPY was modified with a fatty acid, a cathepsin B-cleavable linker, followed by a nuclear localization sequence (NLS), and a DOTA chelator (compound pb12). In this proof-of-concept study, labeling was performed with either native terbium-159 (natTb), as surrogate for 161Tb, or with indium-111 (111In). RESULTS: [natTb]Tb-pb12 showed a preserved high binding affinity to endogenous hY1R on MCF-7 cells and was able to induce receptor activation and internalization similar to the hY1R-preferring [F7,P34]-NPY. Specific internalization of the 111In-labeled conjugate into MCF-7 cells was observed, and importantly, time-dependent nuclear uptake of 111In was demonstrated. Study of metabolic stability showed that the peptide is insufficiently stable in human plasma. This was confirmed by injection of [111In]In-pb12 in nude mice bearing MCF-7 xenograft which showed specific uptake only at very early time point. CONCLUSION: The multifunctional NPY conjugate with a releasable DOTA-NLS unit represents a promising concept for enhanced TRT with Auger electron-emitting radiolanthanides. Our research is now focusing on improving the reported concept with respect to the poor plasmatic stability of this promising radiopeptide.
引用
- Chastel A, Worm DJ, Alves ID, et al. Design, synthesis, and biological evaluation of a multifunctional neuropeptide-Y conjugate for selective nuclear delivery of radiolanthanides. EJNMMI Res. 2020. PMID: 32124111. doi:10.1186/s13550-020-0612-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。